Re­ci­pharm to con­struct new In­di­an fill-fin­ish fa­cil­i­ty as part of ex­ist­ing re­la­tion­ship with Nichep­harm found­ing fam­i­ly'

In­dia is get­ting a man­u­fac­tur­ing boost that will add the ca­pac­i­ty to pro­duce an­oth­er 1 bil­lion in­jecta­bles.

Re­ci­pharm an­nounced the con­struc­tion of a new fill-fin­ish fa­cil­i­ty in Ut­tarak­hand, near Dehradun, in col­lab­o­ra­tion with the Sobti fam­i­ly. The de­vel­op­ment is the lat­est move in a part­ner­ship with the fam­i­ly, which be­gan in 2019 af­ter Re­ci­pharm in­vest­ed in Nichep­harm.

The site will up Re­ci­pharm’s ster­ile fill-fin­ish ser­vice to com­ple­ment al­ready ex­ist­ing lo­ca­tions in France, Ger­many and Italy. The project’s next step is to gain au­tho­riza­tion from Eu­ro­pean reg­u­la­tors.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER